Blandini F - Search Results

1

Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA Mutations.

Caminiti SP, Carli G, Avenali M, Blandini F, Perani D. Caminiti SP, et al. Among authors: blandini f. Mov Disord. 2022 Jan;37(1):106-118. doi: 10.1002/mds.28818. Epub 2021 Oct 1. Mov Disord. 2022. PMID: 34596920

2

Quantitative study of mitochondrial complex I in platelets of parkinsonian patients.

Blandini F, Nappi G, Greenamyre JT. Blandini F, et al. Mov Disord. 1998 Jan;13(1):11-5. doi: 10.1002/mds.870130106. Mov Disord. 1998. PMID: 9452319

3

Role of Autophagy in Parkinson's Disease.

Cerri S, Blandini F. Cerri S, et al. Among authors: blandini f. Curr Med Chem. 2019;26(20):3702-3718. doi: 10.2174/0929867325666180226094351. Curr Med Chem. 2019. PMID: 29484979 Review.

4

The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients.

Cerri S, Ghezzi C, Sampieri M, Siani F, Avenali M, Dornini G, Zangaglia R, Minafra B, Blandini F. Cerri S, et al. Among authors: blandini f. Front Cell Neurosci. 2018 May 18;12:125. doi: 10.3389/fncel.2018.00125. eCollection 2018. Front Cell Neurosci. 2018. PMID: 29867358 Free PMC article.

5

Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine.

Blandini F, Cilia R, Cerri S, Pezzoli G, Schapira AHV, Mullin S, Lanciego JL. Blandini F, et al. Mov Disord. 2019 Jan;34(1):9-21. doi: 10.1002/mds.27583. Epub 2018 Dec 27. Mov Disord. 2019. PMID: 30589955 Review.

6

Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.

Avenali M, Toffoli M, Mullin S, McNeil A, Hughes DA, Mehta A, Blandini F, Schapira AHV. Avenali M, et al. Among authors: blandini f. J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1091-1097. doi: 10.1136/jnnp-2019-320394. Epub 2019 Jun 20. J Neurol Neurosurg Psychiatry. 2019. PMID: 31221723

7

Parkinson's Disease in Women and Men: What's the Difference?

Cerri S, Mus L, Blandini F. Cerri S, et al. Among authors: blandini f. J Parkinsons Dis. 2019;9(3):501-515. doi: 10.3233/JPD-191683. J Parkinsons Dis. 2019. PMID: 31282427 Free PMC article. Review.

8

Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease.

Avenali M, Blandini F, Cerri S. Avenali M, et al. Among authors: blandini f. Front Aging Neurosci. 2020 Apr 21;12:97. doi: 10.3389/fnagi.2020.00097. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32372943 Free PMC article. Review.

9

An update on the use of non-ergot dopamine agonists for the treatment of Parkinson's disease.

Cerri S, Blandini F. Cerri S, et al. Among authors: blandini f. Expert Opin Pharmacother. 2020 Dec;21(18):2279-2291. doi: 10.1080/14656566.2020.1805432. Epub 2020 Aug 17. Expert Opin Pharmacother. 2020. PMID: 32804544 Review.

10

Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells.

Avenali M, Cerri S, Ongari G, Ghezzi C, Pacchetti C, Tassorelli C, Valente EM, Blandini F. Avenali M, et al. Among authors: blandini f. Mov Disord. 2021 May;36(5):1267-1272. doi: 10.1002/mds.28496. Epub 2021 Feb 22. Mov Disord. 2021. PMID: 33617695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters